New IV therapy aims to keep severe heart failure patients stable
NCT ID NCT00610051
Summary
This study is testing whether a continuous intravenous (IV) infusion of a medicine called alprostadil can help keep people with severe, advanced heart failure stable and out of the hospital. About 400 participants will receive either the active medicine or a placebo (inactive solution) for six months to see which group has fewer serious heart-related events or deaths. The goal is to see if this long-term IV treatment can better control the disease for those who are very sick.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical university Vienna
Vienna, Austria
Conditions
Explore the condition pages connected to this study.